Company / Free Cash Flow per Share
Processa Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2013-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.08
FY2016
5-year range
-$0.32 / -$0.08
FY2013-FY2016
Trend
+67.9%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has increased for 3 consecutive years, from $-1.21 in FY2013 to $-0.08 in FY2016.
Based on SEC 10-K filings.
-0.08 in FY2016.
Improved from $-0.32 to $-0.08 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Processa Pharmaceuticals, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2016, free cash flow per share increased 67.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | - | - |
| FY2016 | -$0.08 | +67.9% |
| FY2015 | -$0.25 | +22.3% |
| FY2014 | -$0.32 | +73.7% |
| FY2013 | -$1.21 | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026